Biomarkers of inflammation and infection in critical care
Part of Infections clinical trials.
This study looks at markers of inflammation, infection, and immunity in patients who are in the critical care area. It aims to find early signs of how severe the illness might become, how well treatments work, and if infections will develop.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You are in the intensive care or critical care unit.
- You have had major surgery in the last 24 hours, or you have a suspected or confirmed infection (including sepsis).
- You are not pregnant.
- You or your family agree to participate (consent can be given later if needed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This study observes how doctors treat septic shock in intensive care units. It aims to understand current practices and improve care for patients with severe infections and low blood pressure.
This study is looking at how sepsis affects bone marrow to understand why some people get very sick. If you are in the ICU with a serious infection or another critical illness, you may be eligible to join.
This study tests a new, timely approach to managing sepsis (a severe infection that can harm the body). It aims to improve care in the Emergency Department and Intensive Care Unit, which could help patients recover faster.
This research study measures special blood markers (microRNAs) in patients with septic shock or critical illness to understand how the body responds to severe infection. Results may help doctors better diagnose and treat sepsis in the future.
This study looks at how your immune system and inflammation affect your recovery in the intensive care unit. Researchers want to understand why some patients do better than others.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.